Katsuya Sakai

Mr. Katsuya Sakai


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2014 in Biomedicines
Verified
Journal Article
Open access
PDF file
KMKunio Matsumoto
Kunio Matsumoto
HFHiroshi Funakoshi
Hiroshi Funakoshi
HTHisaaki Takahashi
Hisaaki Takahashi
KSKatsuya Sakai
Katsuya Sakai
Hepatocyte growth factor (HGF) is composed of an α-chain and a β-chain, and these chains contain four kringle domains and a serine protease-like structure, respectively. Activation of the HGF–Met pathway evokes dynamic biological responses that support morphogenesis (e.g., epithelial tubulogenesis), regeneration, and the survival of cells and tissues. Characterizations of conditional Met knockout mice have indicated that the HGF–Met pathway plays important roles in regeneration, protection, and homeostasis in various cells and tissues, which includes hepatocytes, renal tubular cells, and neurons. Preclinical studies designed to address the therapeutic significance of HGF have been performed on injury/disease models, including acute tissue injury, chronic fibrosis, and cardiovascular and neurodegenerative diseases. The promotion of cell growth, survival, migration, and morphogenesis that is associated with extracellular matrix proteolysis are the biological activities that underlie the therapeutic actions of HGF. Recombinant HGF protein and the expression vectors for HGF are biological drug candidates for the treatment of patients with diseases and injuries that are associated with impaired tissue function. The intravenous/systemic administration of recombinant HGF protein has been well tolerated in phase I/II clinical trials. The phase-I and phase-I/II clinical trials of the intrathecal administration of HGF protein for the treatment of patients with amyotrophic lateral sclerosis and spinal cord injury, respectively, are ongoing.

9 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
EMEmiko Mihara
Emiko Mihara
SWSatoshi Watanabe
Satoshi Watanabe
NBNasir K. Bashiruddin
Nasir K. Bashiruddin
NNNozomi Nakamura
Nozomi Nakamura
KMKyoko Matoba
Kyoko Matoba
JTJunichi Takagi
Junichi Takagi
Protein engineering has great potential for devising multifunctional recombinant proteins to serve as next-generation protein therapeutics, but it often requires drastic modifications of the parental protein scaffolds e.g., additional domains at the N/C-terminus or replacement of a domain by another. A discovery platform system, called RaPID (Random non-standard Peptides Integrated Discovery) system, has enabled rapid discovery of small de novo macrocyclic peptides that bind a target protein with high binding specificity and affinity. Capitalizing on the optimized binding properties of the RaPID-derived peptides, here we show that RaPID-derived pharmacophore sequences can be readily implanted into surface-exposed loops on recombinant proteins and maintain both the parental peptide binding function(s) and the host protein function. We refer to this protein engineering method as lasso-grafting and demonstrate that it can endow specific binding capacity toward various receptors into a diverse set of scaffolds that includes IgG, serum albumin, and even capsid proteins of adeno-associated virus, enabling us to rapidly formulate and produce bi-, tri-, and even tetra-specific binder molecules.

7 November 2022 in Nature Biomedical Engineering
Verified
Journal Article
Open access
PDF file
KSKatsuya Sakai
Katsuya Sakai
NSNozomi Sugano-Nakamura
Nozomi Sugano-Nakamura
EMEmiko Mihara
Emiko Mihara
NRNichole Marcela Rojas-Chaverra
Nichole Marcela Rojas-Chaverra
SWSayako Watanabe
Sayako Watanabe
KMKunio Matsumoto
Kunio Matsumoto
Short half-lives in circulation and poor transport across the blood–brain barrier limit the utility of cytokines and growth factors acting as receptor agonists. Here we show that surrogate receptor agonists with longer half-lives in circulation and enhanced transport rates across the blood–brain barrier can be generated by genetically inserting macrocyclic peptide pharmacophores into the structural loops of the fragment crystallizable (Fc) region of a human immunoglobulin. We used such ‘lasso-grafting’ approach, which preserves the expression levels of the Fc region and its affinity for the neonatal Fc receptor, to generate Fc-based protein scaffolds with macrocyclic peptides binding to the receptor tyrosine protein kinase Met. The Met agonists dimerized Met, inducing biological responses that were similar to those induced by its natural ligand. Moreover, lasso-grafting of the Fc region of the mouse anti-transferrin-receptor antibody with Met-binding macrocyclic peptides enhanced the accumulation of the resulting Met agonists in brain parenchyma in mice. Lasso-grafting may allow for designer protein therapeutics with enhanced stability and pharmacokinetics.

Verified
Journal Article
Open access
PDF file
NJNawaphat Jangphattananont
Nawaphat Jangphattananont
HSHiroki Sato
Hiroki Sato
RIRyu Imamura
Ryu Imamura
KSKatsuya Sakai
Katsuya Sakai
YTYumi Terakado
Yumi Terakado
KMKunio Matsumoto
Kunio Matsumoto
Hepatocyte growth factor (HGF) is secreted as an inactive single-chain HGF (scHGF); however, only proteolytically processed two-chain HGF (tcHGF) can activate the MET receptor. We investigated the localization of tcHGF and activated/phosphorylated MET (pMET) using a tcHGF-specific antibody. In day 16.5 mouse embryos, total HGF (scHGF + tcHGF) was mainly localized in smooth muscle cells close to, but separate from, MET-positive epithelial cells in endodermal organs, including the stomach. In the adult stomach, total HGF was localized in smooth muscle cells, and tcHGF was mainly localized in the glandular base region. Immunostaining for pMET and Lgr5-driven green fluorescent protein (GFP) indicated that pMET localization overlapped with Lgr5+ gastric stem cells. HGF promoted organoid formation similar to EGF, indicating the potential for HGF to promote the survival and growth of gastric stem cells. pMET and tcHGF localizations changed during regeneration following gastric injury. These results indicate that MET is constantly activated in gastric stem cells and that the localization of pMET differs from the primary localization of precursor HGF but has a close relationship to tcHGF. Our results suggest the importance of the microenvironmental generation of tcHGF in the regulation of development, regeneration, and stem cell behavior.

25 September 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
RIRyu Imamura
Ryu Imamura
HSHiroki Sato
Hiroki Sato
DVDominic Chih Cheng Voon
Dominic Chih Cheng Voon
TSTakayoshi Shirasaki
Takayoshi Shirasaki
MHMasao Honda
Masao Honda
KMKunio Matsumoto
Kunio Matsumoto
Epithelial tissue is at the forefront of innate immunity, playing a crucial role in the recognition and elimination of pathogens. Met is a receptor tyrosine kinase that is necessary for epithelial cell survival, proliferation, and regeneration. Here, we showed that Met is essential for the induction of cytokine production by cytosolic nonself double-stranded RNA through retinoic acid–inducible gene-I-like receptors (RLRs) in epithelial cells. Surprisingly, the tyrosine kinase activity of Met was dispensable for promoting cytokine production. Rather, the intracellular carboxy terminus of Met interacted with mitochondrial antiviral-signaling protein (MAVS) in RLR-mediated signaling to directly promote MAVS signalosome formation. These studies revealed a kinase activity–independent function of Met in the promotion of antiviral innate immune responses, defining dual roles of Met in both regeneration and immune responses in the epithelium.

25 January 2011 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
KSKatsuya Sakai
Katsuya Sakai
YIYuichi Ishikawa
Yuichi Ishikawa
YMYumiko Mori
Yumiko Mori
MKMiki Kobayashi
Miki Kobayashi
CIChisako Iriyama
Chisako Iriyama
HKHitoshi Kiyoi
Hitoshi Kiyoi